Clinical Trial Update: A Study to Assess the Efficacy, Safety and Tolerability of Different Doses of AZD0780 in Patients With Dyslipidemia [Phase 2]

View source ↗

Summary

Phase 2 study evaluating multiple doses of AZD0780 in adults with dyslipidemia to assess efficacy, safety, and tolerability; study completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• AZD0780

Snippet

Sponsor: AstraZeneca | Conditions: Dyslipidemia | Phase 2 | Status: COMPLETED | Results posted: 2025-11-17